Target intelligence / Profile preview

SHC adaptor protein 2 (SHC2)

Target
SHC2
Molecular classification
Adaptor protein, Signaling protein, Cytoplasmic protein, Src homology domain-containing protein (CH2-PTB-CH1-SH2 domains)
01

Overview

The SHC adaptor protein 2 (SHC2) is an intracellular adaptor protein, a member of the Shc family, that plays a critical role in coupling activated growth factor receptors—especially receptor tyrosine kinases and notably in neuronal cells—to downstream signal transduction pathways. SHC2 contains distinct Src homology 2 (SH2) and phosphotyrosine-binding (PTB) domains, enabling its interaction with phosphorylated tyrosine residues on activated receptors like neurotrophin Trk receptors and EGFR. Lacking intrinsic enzymatic activity, SHC2 functions as a critical scaffold for assembling signaling complexes, linking extracellular stimuli to cellular processes such as proliferation, differentiation, survival, and migration. Deregulation of SHC2 is implicated in diseases including cancer and neurodegeneration. Although SHC2 is a key intracellular adaptor involved in neuronal signal transduction and disease association, it is not typically considered a direct drug target or biomarker.

Other names
ShcBSHC-transforming protein 2SliShc2
02

Mechanism of action

no direct mechanism, as SHC2 is mostly targeted through modulation of associated pathways such as receptor tyrosine kinase inhibitors or downstream effectors

03

Biological functions

Signal transduction (especially downstream of receptor tyrosine kinases and neurotrophin receptors)Mediates activation of MAPK and PI3K/Akt pathwaysCellular organization through protein-protein interactionsCell proliferation and survivalNeuronal differentiation
04

Disease associations

Cancer (deregulation implicated in tumorigenesis)Neurodegenerative diseases (associated with Borrelia Miyamotoi Disease and suspected roles in Alzheimer's)Other neurological disorders
05

Safety considerations

Targeting adaptor proteins can have broad effects on signal transduction, potentially impacting fundamental cellular processes like proliferation or survivalTherapeutic challenges include lack of intrinsic enzymatic activity and potential widespread effects due to its central role in multiple pathways

Beyond the preview

Go deeper on SHC adaptor protein 2 (SHC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHC adaptor protein 2 (SHC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call